Tangent secures $8.6 million to bring IV catheter to market

11/30/2012 | MedCityNews.com

Tangent Medical Technologies, a spinoff of the University of Michigan's Medical Innovation Center, obtained $8.6 million from nine backers in a round of equity financing. The money is expected to be used to market the company's NovaCath system, an FDA-cleared intravenous catheter designed to promote patient comfort, avoid blood spatters and protect patients from pathogen exposure.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA